Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?

References

• LozanoR1NaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
   PubMed Web of Science ®Google Scholar
• YusufSHawkenSÔunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet2004364943893795215364185
   PubMed Web of Science ®Google Scholar
• CapewellSO’FlahertyMWhat explains declining coronary mortality? Lessons and warningsHeart20089491105110818703684
   PubMed Web of Science ®Google Scholar
• EganBMLiJSmallJNietertPJSinopoliAThe growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010Hypertension2014645997100425185135
   PubMed Web of Science ®Google Scholar
• JanusEDBunkerSJKilkkinenAPrevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle Risk Factor Study 2004–2006Intern Med J2008381287988618284462
   PubMed Web of Science ®Google Scholar
• JanusEDTidemanPADunbarJADyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor StudyMed J Aust2010192312713220121678
   PubMed Web of Science ®Google Scholar
• JhaVGarcia-GarciaGIsekiKChronic kidney disease: global dimension and perspectivesLancet2013382988826027223727169
   PubMed Web of Science ®Google Scholar
• JhundPSTavazziLHas the ‘epidemic’ of heart failure been replaced by a tsunami of co-morbidities?Eur J Heart Fail201618550050227072793
   PubMed Web of Science ®Google Scholar
• CerasuoloJOMontero-OdassoMIbañezADoocySLipGYSposatoLADecision-making interventions to stop the global atrial fibrillation-related stroke tsunamiInt J Stroke201712322222828381196
   PubMed Web of Science ®Google Scholar
• Mc NamaraKPDunbarJAPhilpotBMarriottJLReddyPJanusEDPotential of pharmacists to help reduce the burden of poorly managed cardiovascular riskAust J Rural Health2012202677322435766
   PubMed Web of Science ®Google Scholar
• Mc NamaraKPBrekenBDAlzubaidiHTHealth professional perspectives on the management of multimorbidity and polypharmacy for older patients in AustraliaAge Ageing201746229129927836856
   PubMed Web of Science ®Google Scholar
• HoffmannTCLégaréFSimmonsMBShared decision making: what do clinicians need to know and why should they bother?Med J Aust20142011353924999896
   PubMed Web of Science ®Google Scholar
• ClarkCSmithLCloutierLAllied health professional-led interventions for improving control of blood pressure in patients with hypertension: a Cochrane systematic review and meta-analysisJ Hypertens201533Suppl 1e44
   Web of Science ®Google Scholar
• FaheyTSchroederKEbrahimSEducational and organisational interventions used to improve the management of hypertension in primary care: a systematic reviewBr J Gen Pract20055552087588216282005
   PubMed Web of Science ®Google Scholar
• MachadoMBajcarJGuzzoGCEinarsonTRSensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension managementAnn Pharmacother200741111770178117925496
   PubMed Web of Science ®Google Scholar
• MorgadoMPMorgadoSRMendesLCPereiraLJCastelo-BrancoMPharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysisAm J Health Syst Pharm201168324125321258029
   PubMed Web of Science ®Google Scholar
• AguiarPMBritoGCCorrerCJLyra JúniorDPStorpirtisSExploring the quality of systematic reviews on pharmacist interventions in patients with diabetes: an overviewAnn Pharmacother201448788789624692605
   PubMed Web of Science ®Google Scholar
• AntoineSLPieperDMathesTEikermannMImproving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trialsBMC Endocr Disord2014145325001374
   PubMed Web of Science ®Google Scholar
• BolenSDChandarAFalck-YtterCEffectiveness and safety of patient activation interventions for adults with type 2 diabetes: systematic review, meta-analysis, and meta-regressionJ Gen Intern Med20142981166117624733301
   PubMed Web of Science ®Google Scholar
• GormanKMFosterADKaspinLCKindermannSLMillerRMPDB91 Systematic review of diabetes disease management interventionsValue Health2012154A187
   Web of Science ®Google Scholar
• HassaliMANazirSUSaleemFMasoodILiterature review: pharmacists’ interventions to improve control and management in type 2 diabetes mellitusAltern Ther Health Med20152112835
   Web of Science ®Google Scholar
• HusseinMBrownLMPDB59 Cost-effectiveness analysis of medication therapy management in patients with type 2 diabetes in community pharmacy/ambulatory care settings: results from a decision-analytic Markov modelValue Health2012154A181
   Web of Science ®Google Scholar
• PousinhoSMorgadoMFalcãoAAlvesGPharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trialsJ Manag Care Spec Phar2016225493515
   PubMedGoogle Scholar
• CranorCWBuntingBAChristensenDBThe Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care programJ Am Pharm Assoc (Wash)200343217318412688435
   PubMedGoogle Scholar
• CliffordRMDavisWABattyKTDavisTMFremantle Diabetes StudyEffect of a pharmaceutical care program on vascular risk factors in type 2 diabetes. The Fremantle Diabetes StudyDiabetes Care200528477177615793171
   PubMed Web of Science ®Google Scholar
• GreerNBolducJGeurkinkEPharmacist-led chronic disease management: a systematic review of effectiveness and harms compared with usual careAnn Intern Med Epub2016426
   Web of Science ®Google Scholar
• MachadoMBajcarJGuzzoGCEinarsonTRSensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes managementAnn Pharmacother200741101569158217712043
   PubMed Web of Science ®Google Scholar
• KaczorowskiJChambersLWDolovichLImproving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP)BMJ2011342d44221300712
   PubMed Web of Science ®Google Scholar
• RougheadEEBarrattJDRamsayECollaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veteransJ Clin Pharm Ther2011361273221108651
   PubMed Web of Science ®Google Scholar
• AltowaijriAPhillipsCJFitzsimmonsDA systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular diseaseJ Manag Care Pharm201319540841623697478
   PubMed Web of Science ®Google Scholar
• BouvyMLHeerdinkERUrquhartJGrobbeeDEHoeAWLeufkensHGEffect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled studyJ Card Fail20039540441114583903
   PubMed Web of Science ®Google Scholar
• HollandRBrooksbyILenaghanEEffectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trialBMJ20073347603109817452390
   PubMed Web of Science ®Google Scholar
• AraSA literature review of cardiovascular disease management programs in managed care populationsJ Manag Care Pharm200410432634415298531
   PubMedGoogle Scholar
• CaiHDaiHHuYYanXXuHPharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trialsBMC Health Serv Res20131346124188540
   PubMed Web of Science ®Google Scholar
• LowrieRMairFSGreenlawNPharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunctionEur Heart J201233331432422083873
   PubMed Web of Science ®Google Scholar
• ChengWHManzoorBSCavallariLQuality of pharmacist-managed anticoagulation therapy in long-term ambulatory settings: a systematic reviewValue Health2014173A126A127
   Web of Science ®Google Scholar
• SaokaewSPermsuwanUChaiyakunaprukNNathisuwanSSukonthasarnAEffectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysisJ Thromb Haemost20108112418242720831620
   PubMed Web of Science ®Google Scholar
• HarrisonJShawJPHarrisonJEAnticoagulation management by community pharmacists in New Zealand: an evaluation of a collaborative model in primary careInt J Pharm Pract201523317318125250655
   PubMedGoogle Scholar
• BasarabaJEPicardMGeorge-PhillipsKMysakTPharmacists as care providers for stroke patients: a systematic reviewCan J Neurol Sci20154514955
   Web of Science ®Google Scholar
• SalgadoTMMolesRBenrimojSIFernandez-LlimosFPharmacists’ interventions in the management of patients with chronic kidney disease: a systematic reviewNephrol Dial Transplant201227127629221719712
   PubMed Web of Science ®Google Scholar
• BlenkinsoppAAndersonCArmstrongMSystematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart diseaseJ Public Health Med200325214415312848404
   PubMedGoogle Scholar
• SabaMDiepJSainiBDhippayomTMeta-analysis of the effectiveness of smoking cessation interventions in community pharmacyJ Clin Pharm Ther201439324024724749899
   PubMed Web of Science ®Google Scholar
• BrownTJToddAO’MalleyCCommunity pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessationBMJ Open201662e009828
   Web of Science ®Google Scholar
• BrownTJToddAO’MalleyCCommunity pharmacy interventions for public health priorities: a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventionsPublic Health Research, No 422016
   Google Scholar
• MachadoMNassorNBajcarJMGuzzoGCEinarsonTRSensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia managementAnn Pharmacother20084291195120718682540
   PubMed Web of Science ®Google Scholar
• CharroisTLTsuyukiRTComment: sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia managementAnn Pharmacother200943479379419336643
   PubMed Web of Science ®Google Scholar
• CarterBLRogersMDalyJZhengSJamesPAThe potency of team-based care interventions for hypertension: a meta-analysisArch Intern Med2009169191748175519858431
   PubMedGoogle Scholar
• CheemaESutcliffePSingerDRThe impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trialsBr J Clin Pharmacol20147861238124724966032
   PubMed Web of Science ®Google Scholar
• SantschiVChioleroAColosimoALImproving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trialsJ Am Heart Assoc201432e00071824721801
   PubMed Web of Science ®Google Scholar
• TsuyukiRTAl HamarnehYNJonesCAHemmelgarnBRThe Effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trialJ Am Coll Cardiol201667242846285427058907
   PubMed Web of Science ®Google Scholar
• Mc NamaraKGeorgeJO’ReillySEngaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot studyBMC Health Serv Res20101026420819236
   PubMed Web of Science ®Google Scholar
• McNamaraKPO’ReillySLDunbarJAA pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: The PAART CVD pilot projectAnn Pharmacother201246218319122318928
   PubMed Web of Science ®Google Scholar
• McNamaraKPO’ReillySLGeorgeJIntervention fidelity for a complex behaviour change intervention in community pharmacy addressing cardiovascular disease riskHealth Educ Res201530689790926471920
   PubMed Web of Science ®Google Scholar
• DiDonatoKLMayJRLindseyCCImpact of wellness coaching and monitoring services provided in a community pharmacyJ Am Pharm Assoc (2003)2013531142123636151
   PubMed Web of Science ®Google Scholar
• WillisARiversPGrayLJDaviesMKhuntiKThe effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy settingPLoS One201494e9115724690919
   PubMed Web of Science ®Google Scholar
• WinfreyCWortmanSFredeSKunzeNConradWFHeatonPCPharmacist-initiated peripheral arterial disease screening program in a community pharmacy settingJ Am Pharm Assoc2011513373377
   Google Scholar
• ZerumskyKSteinmetzKLHandlerSMRodriguezEGPharmacist detection of peripheral arterial disease through the use of a handheld DopplerPharmacotherapy200525679780215927897
   PubMed Web of Science ®Google Scholar
• TwiggMJThornleyTScobieNIdentification of patients with atrial fibrillation in UK community pharmacy: an evaluation of a new serviceInt J Clin Pharm201638478478727107584
   PubMed Web of Science ®Google Scholar
• LowresNKrassINeubeckLAtrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementationInt J Clin Pharm20153761111112026202627
   PubMed Web of Science ®Google Scholar
• AyorindeAAPorteousTSharmaPScreening for diseases in community pharmaciesInt J Pharm Pract20132134936123683090
   PubMedGoogle Scholar
• ShawJESicreeRAZimmetPZGlobal estimates of the prevalence of diabetes for 2010 and 2030Diabetes Res Clin Pract201087141419896746
   PubMed Web of Science ®Google Scholar
• AlzubaidiHMc NamaraKBrowningCTime to question diabetes self-management support for Arabic-speaking migrants: exploring a new model of careDiabet Med201734334835527864988
   PubMed Web of Science ®Google Scholar
• ZillichAJMcDonoughRPCarterBLDoucetteWRInfluential characteristics of physician/pharmacist collaborative relationshipsAnn Pharmacother200438576477015031418
   PubMed Web of Science ®Google Scholar
• PuspitasariHPCostaDSAslaniPKrassIAn explanatory model of community pharmacists’ support in the secondary prevention of cardiovascular diseaseRes Social Adm Pharm201612110411826001624
   PubMed Web of Science ®Google Scholar
• Mc NamaraKPPetersonGMHughesJCardiovascular disease risk assessment in Australian Community PharmacyHeart Lung Circ201726766767628089788
   PubMed Web of Science ®Google Scholar